112 related articles for article (PubMed ID: 18670465)
21. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
[TBL] [Abstract][Full Text] [Related]
22. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
Kiuchi T; Motoyama Y; Oshika T
Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
[TBL] [Abstract][Full Text] [Related]
23. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study).
Birt CM; Buys YM; Ahmed II; Trope GE;
J Glaucoma; 2010 Sep; 19(7):460-7. PubMed ID: 20051890
[TBL] [Abstract][Full Text] [Related]
25. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
[TBL] [Abstract][Full Text] [Related]
26. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC
Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932
[TBL] [Abstract][Full Text] [Related]
27. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
Martínez A; Sanchez-Salorio M
Acta Ophthalmol; 2010 Aug; 88(5):541-52. PubMed ID: 19799592
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
[TBL] [Abstract][Full Text] [Related]
29. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma.
Mandić Z; Bojić L; Novak-Laus K; Sarić D
Coll Antropol; 2002 Dec; 26(2):595-600. PubMed ID: 12528287
[TBL] [Abstract][Full Text] [Related]
31. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
Konstas AG; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye (Lond); 2004 Sep; 18(9):893-9. PubMed ID: 15002024
[TBL] [Abstract][Full Text] [Related]
32. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
34. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
[TBL] [Abstract][Full Text] [Related]
35. Do adherence rates and glaucomatous visual field progression correlate?
Rossi GC; Pasinetti GM; Scudeller L; Radaelli R; Bianchi PE
Eur J Ophthalmol; 2011; 21(4):410-4. PubMed ID: 21140373
[TBL] [Abstract][Full Text] [Related]
36. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.
Evans DW; Hosking SL; Gherghel D; Bartlett JD
Br J Ophthalmol; 2003 Dec; 87(12):1463-5. PubMed ID: 14660453
[TBL] [Abstract][Full Text] [Related]
37. Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.
Vogel R; Crick RP; Mills KB; Reynolds PM; Sass W; Clineschmidt CM; Tipping R
Ophthalmology; 1992 Oct; 99(10):1505-11. PubMed ID: 1454315
[TBL] [Abstract][Full Text] [Related]
38. Special considerations in low-tension glaucoma.
Krupin T
Can J Ophthalmol; 2007 Jun; 42(3):414-7. PubMed ID: 17508037
[TBL] [Abstract][Full Text] [Related]
39. Visual field survival: the response to timolol therapy in open-angle glaucoma.
Sponsel WE; Dallas NL; Burbridge L
Br J Ophthalmol; 1983 Apr; 67(4):220-7. PubMed ID: 6830740
[TBL] [Abstract][Full Text] [Related]
40. The medical management of primary open-angle glaucoma in the elderly patient.
Schoevaerdts D; Levecq L; Vanpee D; Swine C
Z Gerontol Geriatr; 2003 Apr; 36(2):121-3. PubMed ID: 12720024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
